| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500550 | Farmacia Hospitalaria | 2007 | 20 Pages |
Abstract
Among patients with HIV/AIDS, most of the pharmcokinetic interactions of clinical relevance are attributed to inhibition or induction of hepatic systemic metabolic activity, mainly of CYP3A4.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
P. Amariles, N.A. Giraldo, M.J. Faus,